Description
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
SOMETHING INSIDE YOUR CELLS IS
WORKING AGAINST YOU.
HERE’S WHAT IT IS.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Most people assume a slow metabolism is just bad luck —
something you’re born with, or something that comes with age.
But research has found something more specific.
Inside fat tissue, there’s an enzyme called NNMT.
Its job is to break down Vitamin B3 — the same raw material
your cells need to produce NAD+.
NAD+ is what powers your mitochondria. It’s the molecule
that tells your cells to produce energy rather than store it.
When NAD+ levels are high, cells run efficiently.
When they’re low — which is exactly what NNMT causes —
everything slows down.
Here’s the part that makes it worse:
Research shows NNMT is significantly more active in people
carrying excess body fat. The more it accumulates, the more
it drains NAD+, and the slower cellular metabolism becomes.
It compounds on itself.
5-Amino-1MQ was developed to go in and block that enzyme
before it does its damage.
Not by interfering with hormones. Not by suppressing appetite.
Not by stimulating your heart rate or adrenal system.
By targeting the specific enzyme that’s been quietly
running the metabolic slowdown from the inside.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
WHAT CHANGES WHEN NNMT GETS BLOCKED
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
↳ NAD+ STOPS GETTING DRAINED
With NNMT blocked, Vitamin B3 stays available for what
it was meant to do. Intracellular NAD+ starts to rebuild.
And when NAD+ rises, everything that depends on it
starts working properly again.
↳ CELLS PRODUCE ENERGY INSTEAD OF STORING IT
Mitochondria — your cellular power plants — run on NAD+.
Restore the supply, and cells that were sitting in low-power
mode start generating energy the way they should.
In preclinical research, this shift in cellular energy
expenditure was observed directly in adipose tissue —
the cells changing their behavior, not the subjects
changing their diet.
↳ SIRT1 GETS ACTIVATED
Rising NAD+ triggers SIRT1 — a protein connected to
metabolic regulation, cellular repair, and how efficiently
your body processes what it stores. When SIRT1 is active,
the downstream effects touch energy balance, cholesterol
metabolism, and how cells handle the resources available
to them.
↳ THE RESEARCH DATA POINT WORTH KNOWING
In a controlled preclinical study, subjects receiving
5-Amino-1MQ showed significant reductions in fat mass
and a 30% decrease in fat cell size — with no change in
food consumption. Individual results in research settings
always vary, and human clinical data is still developing.
But the cellular mechanism behind those results is
exactly what 5-Amino-1MQ is designed to activate.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
WHAT RESEARCHERS TEND TO NOTICE
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Individual responses vary. The following reflects
reported research observations only.
EARLY ON (WEEKS 1–2)
The first shift most people report isn’t visible —
it’s felt. A steadier, cleaner kind of energy.
Not the sharp spike-and-crash of a stimulant.
More like the lights turning back on in a room
that’s been running on a dimmer for years.
FURTHER IN (WEEKS 4–8)
This is where body composition observations tend
to begin. Areas with higher concentrations of
metabolically sluggish fat tissue — the kind that
doesn’t shift easily — become more responsive.
Not because 5-Amino-1MQ replaces effort,
but because it removes the cellular ceiling
that was capping the results of effort.
ACROSS A FULL CYCLE (WEEKS 8–12)
Continued metabolic activity, improved energy
consistency, and for many in research contexts,
a body that finally feels like it’s responding.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
THE REASON A CAPSULE MATTERS
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Most compounds in this research space require
cold storage, careful preparation, and precise
dosing equipment. That friction alone stops many
people from ever running a proper protocol.
5-Amino-1MQ is a small molecule — not a fragile
peptide chain. It’s built for oral delivery.
A 2021 pharmacokinetic study confirmed 38.4% oral
bioavailability and a 6.9-hour half-life. It survives
the digestive environment, crosses intestinal membranes,
and reaches systemic circulation intact — from a capsule.
Room temperature storage. No prep. No equipment.
The kind of consistency that makes a 12-week
research protocol actually doable.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
HOW IT COMPARES
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
VS. STIMULANT-BASED SUPPLEMENTS
Fat burners and thermogenics work by stressing your
adrenal system into burning more. The result is a
temporary spike, followed by a crash, followed by
your body adapting and needing more to get the same
effect. 5-Amino-1MQ doesn’t touch the adrenal system.
It works at the enzyme level inside the cell itself.
No tolerance build-up. No crash.
VS. GLP-1 COMPOUNDS
GLP-1 research compounds work from the brain downward —
changing hunger signals, slowing digestion, reducing
appetite. Effective, but systemic. 5-Amino-1MQ works
from the cell upward — changing how fat tissue handles
energy, with no effect on appetite at all. Completely
different biological layer. Some researchers explore both
in combination for that reason.
VS. NAD+ PRECURSORS (NR, NMN)
NR and NMN feed more raw material into the NAD+
production line. That helps — but if NNMT is still
active and draining the supply as fast as it comes in,
you’re filling a bucket with a hole in the bottom.
5-Amino-1MQ addresses the hole directly.
Then NAD+ builds on its own.
VS. AOD-9604
AOD-9604 activates specific receptors in fat tissue
to directly trigger fat breakdown — a receptor-level
mechanism. 5-Amino-1MQ works one layer deeper:
at the enzyme inside the cell that controls whether
fat tissue is metabolically active or dormant in the
first place. Different entry point. Some research
protocols stack both for that reason.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
DOSING REFERENCE
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
→ 50mg once daily — standard starting point
Take with food, in the morning
→ 50mg twice daily — morning + early afternoon
For those looking to maintain steadier
NAD+ levels across the full day
→ Evening dosing not recommended
Increased cellular energy output can
interfere with sleep quality
→ Cycle: 8–12 weeks on / 4–8 weeks off
Prevents the body from adapting;
keeps the compound at full effectiveness
→ 12-week cycle = approx. 3 bottles at 50mg/day
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
PRODUCT SPECS
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Compound: 5-Amino-1-methylquinolinium (5-Amino-1MQ)
Amount per capsule: 50mg
Purity: ≥99% (HPLC verified)
Form: Oral capsule
Bioavailability: 38.4% oral (confirmed, 2021 pharmacokinetic study)
Half-Life: 6.9 hours
Stimulants: None
Hormonal activity: None
Storage: Room temperature | No refrigeration required
Testing: Third-party tested | Batch COA available on request
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
IMPORTANT
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
For research purposes only.
Not for human or veterinary use.
Not intended to diagnose, treat, cure, or prevent any condition.
Individual responses vary. Current published data is primarily
from preclinical models. Human clinical trials are ongoing.
Consult a qualified professional before use.